Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 12, 2019

Do GLP‐1 Receptor Agonists and SGLT2 Inhibitors Lower CV Events in Black Patients With Type 2 Diabetes?

Diabetes, Obesity & Metabolism


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Do GLP‐1RA and SGLT‐2i Reduce Cardiovascular Events in Black Patients With Type 2 Diabetes?: A Systematic Review and Meta‐Analysis
Diabetes Obes Metab 2019 Jun 05;[EPub Ahead of Print], BM Mishriky, JR Powell, JA Wittwer, JX Chu, KA Sewell, Q Wu, DM Cummings

Further Reading